BDTX icon

Black Diamond Therapeutics

96 hedge funds and large institutions have $212M invested in Black Diamond Therapeutics in 2024 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 38 increasing their positions, 21 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
96
Holders Change
+6
Holders Change %
+6.67%
% of All Funds
1.39%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
22
Increased
38
Reduced
21
Closed
16
Calls
$7.05M
Puts
$9.61M
Net Calls
-$2.56M
Net Calls Change
-$2.78M
Name Holding Trade Value Shares
Change
Shares
Change %
Qube Research & Technologies (QRT)
101
Qube Research & Technologies (QRT)
United Kingdom
-$573K -123,034 Closed
CF
102
Cantor Fitzgerald
New York
-$489K -105,039 Closed
AGM
103
Alpine Global Management
New York
-$166K -35,583 Closed
Bank of Montreal
104
Bank of Montreal
Ontario, Canada
-$139K -28,593 Closed
AG
105
Algert Global
California
-$133K -28,501 Closed
Susquehanna International Group
106
Susquehanna International Group
Pennsylvania
-$118K -25,266 Closed
SG Americas Securities
107
SG Americas Securities
New York
-$108K -23,146 Closed
MTIM
108
Marathon Trading Investment Management
Pennsylvania
-$89.1K -19,116 Closed
GCP
109
GSA Capital Partners
United Kingdom
-$78K -16,814 Closed
Man Group
110
Man Group
United Kingdom
-$57.9K -12,416 Closed
NFSG
111
Newbridge Financial Services Group
Florida
-$2.33K -500 Closed